Guest blogger Jessica Melore, day 2... While I couldn’t control all parts of my cancer journey, I made it my mission to reclaim as much of the other aspects of my life as I could. Just as when I’d ...
I am a survivor of Non Hodgkins Lymphoma. Here is my story: On June 4 2011, my son died. He was 43 years old. He died of acute liver failure brought on by alcoholism. He was also bipolar. His death put me in a tailsp...
In February we introduced you to guest blogger Jessica Melore, who told the story of her blood cancer journey. Here her journey continues… I value a sense of control in my life. For me this transl...
As a member of “Alliance for a Stronger FDA” LLS senior director of legislative affairs Emily Shetty recently participated in a Capitol Hill day, during which members of the coalition met with members and ...
In a special report – Foundations Fuel Risky Biotech Ventures - about nonprofits investing in biotechnology companies, FierceBiotech interviews LLS Senior Vice President of Research Richard C. Winneker, Ph.D. ab...
A Florida bill that would equalize cost sharing for both cancer patients who rely on oral therapies and patients who get their chemotherapy intravenously, took a giant step closer to becoming reality with unanimous pa...
Advances in T-cell immunotherapy continued to garner widespread interest this week with an article in The Lancet Oncology, and coverage by WHYY news in Philadelphia. The Lancet article focused on a study out o...
The issue of drug shortages – in particular, generic injectables - is a major concern for patients with blood cancers. The issue of drug shortages has been in the news for some time, most recently last month whe...
Kris Stebbins, Guest Blogger Families give love, various types of support, and some may think they understand, but if they have not had CML, they don’t understand. Finding the right kind of support is vi...
The Leukemia & Lymphoma Society (LLS) and the Cool Kids Campaign are partnering to raise awareness about pediatric blood cancer. Both organizations’ missions align in the goal of improving the qualit...
Thanks to our community news partners, wonderful volunteers, participants and honorees, we got some amazing exposure at the Big Climb this last weekend. We're starting a roundup right here. Please bookmark...
[In addition to The Leukemia Cup Regatta - www.leukemiacup.org/wa, we have a new program called Sailing for Cancer Cures (SFCC). Through this innovative program, aspiring sailors commit to fundraise on behalf of the L...
Today, along with many of my colleagues at The Leukemia & Lymphoma Society, I eagerly read the Brief Report published online in The New England Journal of Medicine detailing the treatment of two children with an a...
FasterCures, a nonprofit organization that, as its name suggests, is dedicated to accelerating medical breakthroughs, recently published a special report: “Honest Brokers for Cures – How Venture Phi...
Another exciting advance in adoptive T-cell immunotherapy made news today thanks to publication of a study by researchers at Memorial-Sloan Kettering Cancer Center (MSKCC) in the journal Science Translational Medicine...
Judy Karp, MD, of Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, in Baltimore, has been a great ally to LLS, for more than 20 years. She served as a National Board member and has devoted countless hours revi...
We are pleased to announce the availability of the updated publication Blood and Marrow Stem Cell Transplantation. The content for this booklet was reviewed by Jane Liesveld, MD, Professor, Department of Medicine, Hem...
LLS is featured today in supplements in two major top-tier media outlets: Fortune magazine and The Washington Post. Both supplements include full-page Someday is Today ads, as well as editorial content. Fort...
From left to right: Dr. Wayne Taylor, and Luke Webb, LLS advocates LLS advocacy staff and volunteers continued to make progress this week in helping to advance a Florida bill that would ensure parity fo...
